BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7738620)

  • 1. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
    Quiet CA; Ferguson DJ; Weichselbaum RR; Hellman S
    J Clin Oncol; 1995 May; 13(5):1144-51. PubMed ID: 7738620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes.
    Quiet CA; Ferguson DJ; Weichselbaum RR; Hellman S
    J Clin Oncol; 1996 Dec; 14(12):3105-11. PubMed ID: 8955655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
    Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
    Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of subcutaneous mastectomy with radical mastectomy.
    Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y
    Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.
    Huseby RA; Ownby HE; Frederick J; Brooks S; Russo J; Brennan MJ
    J Clin Oncol; 1988 Jan; 6(1):83-8. PubMed ID: 3335894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
    Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger.
    Floyd SR; Buchholz TA; Haffty BG; Goldberg S; Niemierko A; Raad RA; Oswald MJ; Sullivan T; Strom EA; Powell SN; Katz A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):358-64. PubMed ID: 16887288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
    Mansour EG; Gray R; Shatila AH; Osborne CK; Tormey DC; Gilchrist KW; Cooper MR; Falkson G
    N Engl J Med; 1989 Feb; 320(8):485-90. PubMed ID: 2915651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
    Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
    Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
    Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.